Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | AZD5863 |
Synonyms | |
Therapy Description |
Limited information is currently available on AZD5863, a putative bispecific antibody targeting CLDN18.2 and CD3 (Aug 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AZD5863 | AZD 5863|AZD-5863 | CD3 Antibody 92 CLDN18.2 Antibody 18 | Limited information is currently available on AZD5863, a putative bispecific antibody targeting CLDN18.2 and CD3 (Aug 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06005493 | Phase Ib/II | AZD5863 | Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors | Recruiting | USA | NLD | GBR | 4 |